Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Xspray Pharma Major Shareholding Notification 2022

Apr 25, 2022

3129_iss_2022-04-25_82063192-17b9-41c9-b1ce-1523b5f128a5.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer XSpray Pharma AB (publ)

Holder

Swedbank Robur Fonder AB

Instrument

Instrument Aktier SE0009973563
Before the transaction
Shares 1,101,502
Voting rights 1,101,502
Transaction
Reason for major shareholding notification Sell
Date 20/04/2022
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 901,502
Directly held voting rights 901,502
Indirectly held voting rights 0
Percentage
Directly held shares 4.36 %
Directly held voting rights 4.36 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
4.36 % 901,502
4.36 % 901,502
Name
Mia Metso Ekberg
Phone
08-58597525
Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25